Federal grant · National Institutes of Health

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Status
Open
Posted
Jun 9, 2026
Closes
Sep 25, 2028
Est. total funding
—
Award range
—
Expected awards
—
Opportunity number
PAR-27-026
Who can apply

Eligible applicants

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

About this grant

The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder.

Instrument
Grant
Activity
Health
Assistance listings
93.279
Cost sharing
Not required
Last updated
Aug 27, 2026

From Grants.gov's public daily extract of Oct 25, 2026. Agency contacts, full eligibility and application packages are on Grants.gov; always confirm deadlines there before applying.

Find more grants your organization can apply for — free →
Search every open federal grant by applicant type, agency and activity. No credit card.
Get free alerts

More open grants from Department of Health and Human Services · All open federal grants